このエピソードについて
In this episode of TechPrep: Rapid PTCB Review, we review hepatitis C virus (HCV) infection with a focused, exam-relevant approach tailored to pharmacy technician practice and the PTCB exam. Learners will explore how HCV affects the liver, the progression and potential complications of chronic infection, and how advances in antiviral therapy have changed the treatment of hepatitis C.
The episode connects HCV fundamentals to medication therapy by reviewing direct-acting antiviral (DAA) medications, their role in achieving viral eradication, and key considerations surrounding treatment and adherence. Emphasis is placed on medication safety, drug interactions, and the importance of completing therapy—essential knowledge for pharmacy technicians supporting patients with HCV.
What You'll Learn- The basic pathophysiology and transmission of hepatitis C
- How acute and chronic HCV infection can affect the liver
- Common complications associated with untreated chronic HCV
- Direct-acting antiviral medications and their basic role in treatment
- Key medication safety, adherence, and drug interaction considerations
- Hepatitis C is a viral infection that can lead to serious chronic liver disease if left untreated
- Modern direct-acting antivirals can effectively cure most HCV infections
- Understanding HCV treatment strengthens infectious disease and pharmacology knowledge
- Antiviral therapy and medication safety are high-yield topics for the PTCB exam
✅ Want to master high-yield pharmacology topics for the PTCB exam?
Thousands of pharmacy technician students trust TechPrep for clear explanations, exam-focused review, and real-world relevance.
👉 Start learning today at PharmTechReview.com
#TechPrep #PTCBReview #HepatitisC #HCV
#PTCBPrep #PharmacyTechnician #PharmacologyBasics #AntiviralTherapy
